The quantitative molecular diagnosis of cytokeratin-19 (CK19) and carcinoembryonic antigen (CEA) that target cancer cells in axillary seroma showed that they are a predictor of locoregional recurrence in mastectomized BC patients (110). This evidence concerns the gene CEACAM5 and breast cancer.